Related Experiment Video
Updated: May 15, 2026

05:45
Generation and Downstream Analysis of Single-Cell and Single-Nuclei Transcriptomes in Brain Organoids
Published on: March 29, 2024
Pathway analysis of the human brain transcriptome in disease
Tomas Kavanagh1, James D Mills, Woojin S Kim
1School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, 2052, Australia.
Journal of Molecular Neuroscience : MN
|December 25, 2012
Summary
Pathway analysis helps uncover gene regulation in complex diseases using brain transcriptome data. This method aids in identifying novel causes of disease through differential gene expression and next-generation sequencing insights.
Area of Science:
- Genomics
- Bioinformatics
- Neuroscience
Background:
- Pathway analysis is crucial for understanding biological significance of differentially regulated genes.
- Genome-wide studies using microarrays and RNA-Seq generate vast amounts of data.
- Deep sequencing reveals previously uncharacterized genomic elements.
Purpose of the Study:
- To provide an overview of pathway analysis in the human brain transcriptome.
- To explore the relevance of pathway analysis in understanding complex diseases.
- To outline successful data gathering and analysis approaches.
Main Methods:
- Utilizing pathway analysis to identify perturbed genes within a biological context.
- Employing microarrays and RNA-Seq for genome-wide data generation.
- Leveraging next-generation sequencing for deeper resolution, including isoform diversity and SNPs.
Main Results:
- Pathway analysis facilitates the exploration of mechanisms in complex diseases.
- Differential gene expression is key to finding novel disease causatives.
- Next-generation sequencing enhances the identification of genetic variations.
Conclusions:
- Pathway analysis is a powerful tool for interrogating large-scale genomic data.
- Understanding gene regulation through pathway analysis is vital for complex disease research.
- This approach offers significant potential for discovering underlying causes of neurological disorders.

